Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study.
Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study.
复制标题
DOI：
10.1186/s10194-020-01183-6
复制
发表时间：
2020-09-24
期刊：
影响因子：
--
通讯作者：
Ismail II
中科院分区：
文献类型：
--
作者：
Al-Hashel JY;Ismail II
自宣布COVID-19为大流行以来，全球医疗系统在管理慢性病患者方面面临巨大挑战。偏头痛患者特别容易受到医疗护理不足的影响。我们的目的是调查COVID-19大流行对偏头痛患者的“现实世界”影响，并确定不良结局的风险因素。我们在2020年7月15日至7月30日期间进行了一项在线自我报告调查，其中包括人口统计学，偏头痛相关，COVID-19特定和整体心理社会变量。我们从头痛诊所登记处和社交媒体招募了一批偏头痛患者，以完成一项匿名调查。结果包括人口统计学变量、封锁期间偏头痛频率和严重程度的变化、与治疗医生的沟通、偏头痛治疗的依从性、获得药物的困难、药物过度使用、焦虑和/或抑郁症状、睡眠和饮食习惯紊乱、屏幕时间暴露、大流行期间的工作、传统药物的使用、肉毒杆菌注射取消的影响、以及疫情期间的整体担忧和担忧。共有1018名患者完成了调查。在受访者中，859人（84.3%）为女性; 733人（71.9%）年龄在20至40岁之间，630人（61.8%）已婚，466人（45.7%）报告在疫情期间工作。与大流行前相比，607名受访者（59.6%）报告偏头痛频率增加，163名（16%）报告频率减少，105名（10.3%）转化为慢性偏头痛。653名（64.1%）受访者报告严重程度增加。大多数受访者; 626例（61.5%）未与神经科医生沟通，477例（46.9%）报告治疗依从性，597例（58.7%）报告过度使用镇痛药。在接受肉毒杆菌注射的受访者中，取消肉毒杆菌注射对150名受访者（66.1%）产生了负面影响。41名受访者（4%）感染了COVID-19; 26名（63.4%）报告在感染期间头痛恶化。794人（78.1%）报告了睡眠障碍，809人（79.5%）报告有焦虑和/或抑郁症状。COVID-19大流行对偏头痛患者产生整体负面影响。确定了几个不良结局的风险因素。应验证和实施长期策略，为偏头痛患者提供优质护理，重点是心理健康。
Since the declaration COVID-19 as a pandemic, healthcare systems around the world have faced a huge challenge in managing patients with chronic diseases. Patients with migraine were specifically vulnerable to inadequate medical care. We aimed to investigate the “real-world” impact of COVID-19 pandemic on migraine patients, and to identify risk factors for poor outcome. We administered an online, self-reported survey that included demographic, migraine-related, COVID-19-specific and overall psychosocial variables between July 15 and July 30, 2020. We recruited a sample of patients with migraine from headache clinic registry and via social media to complete an anonymous survey. Outcomes included demographic variables, change in migraine frequency and severity during the lockdown period, communication with treating physician, compliance to migraine treatment, difficulty in getting medications, medication overuse, symptoms of anxiety and/or depression, sleep and eating habits disturbance, screen time exposure, work during pandemic, use of traditional medicine, effect of Botox injection cancellation, and overall worries and concerns during pandemic. A total of 1018 patients completed the survey. Of the respondents, 859 (84.3%) were females; 733 (71.9%) were aged 20 to 40 years, 630 (61.8%) were married, and 466 (45.7%) reported working during the pandemic. In comparison to pre-pandemic period, 607 respondents (59.6%) reported increase in migraine frequency, 163 (16%) reported decrease in frequency, and 105 (10.3%) transformed to chronic migraine. Severity was reported to increase by 653 (64.1%) respondents. The majority of respondents; 626 (61.5%) did not communicate with their neurologists, 477 (46.9%) reported compliance to treatment, and 597 (58.7%) reported overuse of analgesics. Botox injections cancellation had a negative impact on 150 respondents (66.1%) from those receiving it. Forty-one respondents (4%) were infected with COVID-19; 26 (63.4%) reported worsening of their headaches amid infection period. Sleep disturbance was reported by 794 (78.1%) of respondents, and 809 (79.5%) reported having symptoms of anxiety and/or depression. COVID-19 pandemic had an overall negative impact on patients with migraine. Several risk factors for poor outcome were identified. Long-term strategies should be validated and implemented to deliver quality care for patients with migraine, with emphasis on psychosocial well-being.
登录
查看更多内容
影响因子：
3.3
作者：
Aguggia, M.;Saracco, M. G.
通讯作者：
Saracco, M. G.
影响因子：
9.9
作者：
Lipton, RB;Scher, AI;Stewart, WF
通讯作者：
Stewart, WF
影响因子：
5
作者：
Bobker, Sarah M.;Robbins, Matthew S.
通讯作者：
Robbins, Matthew S.
影响因子：
4.9
作者：
Rossi, P;Di Lorenzo, G;Nappi, G
通讯作者：
Nappi, G
影响因子：
5
作者：
Bigal, Marcelo E.;Serrano, Daniel;Lipton, Richard B.
通讯作者：
Lipton, Richard B.